Annual CFO
-$253.58 M
+$36.47 M+12.57%
31 December 2023
Summary:
Sana Biotechnology annual cash flow from operations is currently -$253.58 million, with the most recent change of +$36.47 million (+12.57%) on 31 December 2023. During the last 3 years, it has fallen by -$115.60 million (-83.78%). SANA annual CFO is now -196.52% below its all-time high of -$85.52 million, reached on 31 December 2019.SANA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$51.82 M
+$6.72 M+11.48%
30 September 2024
Summary:
Sana Biotechnology quarterly cash flow from operations is currently -$51.82 million, with the most recent change of +$6.72 million (+11.48%) on 30 September 2024. Over the past year, it has increased by +$11.73 million (+18.46%). SANA quarterly CFO is now -75.38% below its all-time high of -$29.55 million, reached on 31 March 2020.SANA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$227.95 M
+$11.73 M+4.89%
30 September 2024
Summary:
Sana Biotechnology TTM cash flow from operations is currently -$227.95 million, with the most recent change of +$11.73 million (+4.89%) on 30 September 2024. Over the past year, it has increased by +$49.74 million (+17.91%). SANA TTM CFO is now -671.49% below its all-time high of -$29.55 million, reached on 31 March 2020.SANA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SANA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.6% | +18.5% | +17.9% |
| 3 y3 years | -83.8% | -2.6% | -27.7% |
| 5 y5 years | - | - | - |
SANA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -83.8% | +12.6% | -2.6% | +52.9% | -27.7% | +29.7% |
| 5 y | 5 years | -196.5% | +12.6% | -75.4% | +52.9% | -671.5% | +29.7% |
| alltime | all time | -196.5% | +12.6% | -75.4% | +52.9% | -671.5% | +29.7% |
Sana Biotechnology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$51.82 M(-11.5%) | -$227.95 M(-4.9%) |
| June 2024 | - | -$58.54 M(-10.8%) | -$239.68 M(-0.1%) |
| Mar 2024 | - | -$65.63 M(+26.3%) | -$239.94 M(-5.4%) |
| Dec 2023 | -$253.58 M(-12.6%) | -$51.96 M(-18.2%) | -$253.58 M(-8.7%) |
| Sept 2023 | - | -$63.55 M(+8.1%) | -$277.69 M(-0.4%) |
| June 2023 | - | -$58.80 M(-25.8%) | -$278.94 M(-4.3%) |
| Mar 2023 | - | -$79.27 M(+4.2%) | -$291.61 M(+0.5%) |
| Dec 2022 | -$290.05 M | -$76.07 M(+17.4%) | -$290.05 M(-10.5%) |
| Sept 2022 | - | -$64.80 M(-9.3%) | -$324.08 M(+4.6%) |
| June 2022 | - | -$71.48 M(-8.0%) | -$309.77 M(+11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$77.71 M(-29.4%) | -$278.85 M(+11.1%) |
| Dec 2021 | -$251.05 M(+81.9%) | -$110.10 M(+118.1%) | -$251.05 M(+40.6%) |
| Sept 2021 | - | -$50.49 M(+24.5%) | -$178.51 M(+7.8%) |
| June 2021 | - | -$40.56 M(-18.7%) | -$165.54 M(+4.5%) |
| Mar 2021 | - | -$49.91 M(+32.9%) | -$158.35 M(+14.8%) |
| Dec 2020 | -$137.98 M(+61.3%) | -$37.56 M(+0.1%) | -$137.98 M(+37.4%) |
| Sept 2020 | - | -$37.51 M(+12.4%) | -$100.42 M(+59.6%) |
| June 2020 | - | -$33.37 M(+12.9%) | -$62.91 M(+112.9%) |
| Mar 2020 | - | -$29.55 M | -$29.55 M |
| Dec 2019 | -$85.52 M | - | - |
FAQ
- What is Sana Biotechnology annual cash flow from operations?
- What is the all time high annual CFO for Sana Biotechnology?
- What is Sana Biotechnology annual CFO year-on-year change?
- What is Sana Biotechnology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Sana Biotechnology?
- What is Sana Biotechnology quarterly CFO year-on-year change?
- What is Sana Biotechnology TTM cash flow from operations?
- What is the all time high TTM CFO for Sana Biotechnology?
- What is Sana Biotechnology TTM CFO year-on-year change?
What is Sana Biotechnology annual cash flow from operations?
The current annual CFO of SANA is -$253.58 M
What is the all time high annual CFO for Sana Biotechnology?
Sana Biotechnology all-time high annual cash flow from operations is -$85.52 M
What is Sana Biotechnology annual CFO year-on-year change?
Over the past year, SANA annual cash flow from operations has changed by +$36.47 M (+12.57%)
What is Sana Biotechnology quarterly cash flow from operations?
The current quarterly CFO of SANA is -$51.82 M
What is the all time high quarterly CFO for Sana Biotechnology?
Sana Biotechnology all-time high quarterly cash flow from operations is -$29.55 M
What is Sana Biotechnology quarterly CFO year-on-year change?
Over the past year, SANA quarterly cash flow from operations has changed by +$11.73 M (+18.46%)
What is Sana Biotechnology TTM cash flow from operations?
The current TTM CFO of SANA is -$227.95 M
What is the all time high TTM CFO for Sana Biotechnology?
Sana Biotechnology all-time high TTM cash flow from operations is -$29.55 M
What is Sana Biotechnology TTM CFO year-on-year change?
Over the past year, SANA TTM cash flow from operations has changed by +$49.74 M (+17.91%)